Presentation is loading. Please wait.

Presentation is loading. Please wait.

Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization.

Published byMoris Peters Modified over 6 years ago

Similar presentations

Presentation on theme: "Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization."— Presentation transcript:

1 Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection  Ningxin Qin, M.M., Qiuju Chen, Ph.D., Qingqing Hong, M.D., Renfei Cai, M.D., Hongyuan Gao, M.D., Yun Wang, M.D., Lihua Sun, M.D., Shaozhen Zhang, M.D., Haiyan Guo, M.D., Yonglun Fu, M.D., Ai Ai, M.D., Hui Tian, M.D., Qifeng Lyu, Ph.D., Salim Daya, MBChB, Yanping Kuang, M.D.  Fertility and Sterility  Volume 106, Issue 2, Pages e1 (August 2016) DOI: /j.fertnstert Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Serum hormone profiles in the three ovarian stimulation groups. The serum hormone of FSH, LH, E2, and P changes in three groups including conventional group, late follicular phase group, and luteal phase group. Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

3 Supplemental Figure 1 Different stimulation approaches in three ovarian stimulation groups. The protocol of three stimulation groups included conventional group, late follicular phase group, and luteal phase group. Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization."

Similar presentations

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Pregnancy outcome of in vitro fertilization after Essure and laparoscopic management of hydrosalpinx: a systematic review and meta-analysis  Bin Xu, M.D.,

Pregnancy outcome of in vitro fertilization after Essure and laparoscopic management of hydrosalpinx: a systematic review and meta-analysis  Bin Xu, M.D.,
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.

Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.
Genome-based expression profiling as a single standardized microarray platform for the diagnosis of endometrial disorder: an array of 126-gene model 

Genome-based expression profiling as a single standardized microarray platform for the diagnosis of endometrial disorder: an array of 126-gene model 
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.

Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.
Age at menarche: a predictor of diminished ovarian function?

Age at menarche: a predictor of diminished ovarian function?
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.

Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.
Infertility evaluation and treatment among women in the United States

Infertility evaluation and treatment among women in the United States
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Pregnancy outcome of in vitro fertilization after Essure and laparoscopic management of hydrosalpinx: a systematic review and meta-analysis  Bin Xu, M.D.,

Pregnancy outcome of in vitro fertilization after Essure and laparoscopic management of hydrosalpinx: a systematic review and meta-analysis  Bin Xu, M.D.,
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Rene Ecochard, M. D. , Ph. D. , Thomas Bouchard, M. D. , Rene Leiva, M

Rene Ecochard, M. D. , Ph. D. , Thomas Bouchard, M. D. , Rene Leiva, M
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol)  Yanping Kuang, Qiuju Chen,

Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol)  Yanping Kuang, Qiuju Chen,
Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause  Linlin Cui, M.D., Ph.D., Yingying.

Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause  Linlin Cui, M.D., Ph.D., Yingying.

Similar presentations

Ads by Google